From cloudy to clear: visualising complex data privacy information
April 17, 2026 | clinical trials, communication, health literacy
Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.
For the final instalment of our Health Literacy series, we’re sharing another example of how we apply clear communication principles in practice. Here, we explore how we approached a crucial topic in clinical research: participant data.
Medical data is private – it’s sensitive and not something you want to share with strangers. The lack of transparency around how clinical trial data is stored and used can be a major barrier to participation, particularly for underrepresented communities.
We understand the complexity that comes with this topic. There are so many regulations, nuances, and technicalities to consider, which often means the information reads like a Terms & Conditions page. Although the reader has been “informed”, have they really read it? And more importantly, do they really understand?
Our “before” and “after” example shows how a simple flow diagram can help to translate this critical information so anyone can understand how their personal data may be shared.
Before:
The language is contractual and uses technical terms withoutcontext. It’s difficult to know what data your doctor, a researcher, or thebroader scientific community might be able to see.
After:
We’ve broken this information down into a flow diagram, clearly calling out the steps in place to ensure personal data are not identifiable. We made use of visual cues to emphasise that the data becomes more difficult to identify when it is processed and shared. Finally, using real examples of the types of data that may be collected helps provide the transparency readers are looking for.
Ultimately, we’ve provided a clear, visual commitment, supported with examples, to illustrate exactly how readers can expect their personal data to be used.
Clear communication about participant data isn’t just a regulatory requirement – it’s essential for building trust in clinical research. By presenting complex information in ways that people can easily understand, we can help more participants make informed decisions about taking part in clinical trials.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
How is generative AI transforming clinical trials?
Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.
Content for all – how to connect with neurodiverse audiences
Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.
Cuttsy+Cuttsy launches ccura: AI powered, always human
Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its…
Two Sides of the Same Coin: Patient Engagement vs Patient Involvement
Unpack the difference between patient engagement and patient involvement.
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering…
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective…
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there’s still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.